| ||||||||||||||||||||||||||||||||||||||||||||||||||||||
(Circulation. 2006;113:2675.)
© 2006 American Heart Association, Inc.
An extract of the first 250 words of the full text is provided, because this article has no abstract. |
| SINGLE-GENE MUTATIONS AND INCREASED LEFT VENTRICULAR WALL THICKNESS IN THE COMMUNITY: THE FRAMINGHAM HEART STUDY, by Morita et al. |
|---|
-galactosidase A (GLA), and several mitochondrial genes are associated with rare familial cardiomyopathies; their contribution to LVH in the community is unknown, however. Morita et al identified the prevalence and clinical features of single-gene mutations in adults in the community with increased LVWT in the absence of obvious secondary forms of hypertrophy. Among 1862 Framingham Heart Study participants, 50 had unexplained increased LVWT. Eight subjects (16%) had sarcomere protein gene mutations and one (2%) had a GLA mutation. Therefore, approximately 0.5% of the general population over age 45 has increased unexplained LVWT and a single-gene mutation that probably accounts for their hypertrophy. Increased LVWT in the community is a heterogeneous condition, and additional investigation of the prevalence and clinical features of single-gene mutations in other community-based cohorts will help improve our understanding of the broad spectrum of genetic causes of increased LVWT. See p 2697.
| AEROBIC CAPACITY IN PATIENTS ENTERING CARDIAC REHABILITATION, by Ades et al. |
|---|
Related Articles:
Circulation 2006 113: e848-e849.
Circulation 2006 113: e850-e851.
Circulation 2006 113: e852.
Circulation 2006 113: e853.
Circulation 2006 113: e854.
Circulation 2006 113: 2713-2723.
Circulation 2006 113: 2697-2705.
Circulation 2006 113: 2706-2712.
|
Circulation Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 2006 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |